FindTrial
Sign In

Follitropin delta

DRUG15 trials

Sponsors

Ferring Pharmaceuticals, Clinique Ovo, Peter Kovacs MD, University of Luebeck, Fundación para la Investigación del Hospital Clínico de Valencia

Conditions

Controlled Ovarian SimulationControlled Ovarian StimulationFertilityIVFInfertilityInfertility, FemaleIntrauterine InseminationLow Ovarian Reserve

Phase 1

Rekovelle PK Trial in Chinese Women
CompletedNCT04150861
Ferring PharmaceuticalsInfertility
Start: 2019-06-23End: 2019-12-16Updated: 2023-02-14
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
TerminatedNCT06466486
Ferring PharmaceuticalsFertility
Start: 2024-06-14End: 2025-12-03Updated: 2026-03-30
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
TerminatedNCT06511791
Ferring PharmaceuticalsInfertility
Start: 2024-07-15End: 2025-10-16Updated: 2026-03-30

Phase 2

Personalized Insemination Treatment Study
CompletedNCT03830723
Clinique OvoInfertility, Intrauterine Insemination, Reproduction
Start: 2020-01-09End: 2021-09-27Updated: 2022-09-13

Phase 3

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women
CompletedNCT03228680
Ferring PharmaceuticalsInfertility
Start: 2017-07-29End: 2019-07-08Updated: 2023-08-24
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women
CompletedNCT03296527
Ferring PharmaceuticalsControlled Ovarian Simulation
Start: 2017-12-01End: 2020-07-26Updated: 2023-08-24
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)
CompletedNCT03738618
Ferring PharmaceuticalsInfertility, Female
Start: 2018-10-29End: 2020-12-21Updated: 2024-01-18
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)
CompletedNCT03740737
Ferring PharmaceuticalsInfertility
Start: 2018-10-26End: 2020-11-11Updated: 2024-01-18
Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)
RecruitingNCT07816562
Fundación para la Investigación del Hospital Clínico de ValenciaLow Ovarian Reserve, Poor Ovarian Response
Start: 2024-09-17End: 2028-01-01Target: 126Updated: 2026-09-11

Unknown Phase

Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures
CompletedNCT03393780
Ferring PharmaceuticalsControlled Ovarian Stimulation
Start: 2018-03-16End: 2020-07-17Updated: 2023-02-09
Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®
TerminatedNCT03697031
Ferring PharmaceuticalsControlled Ovarian Stimulation
Start: 2018-09-01End: 2020-12-31Updated: 2023-12-12
Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice
CompletedNCT04503707
Ferring PharmaceuticalsControlled Ovarian Stimulation
Start: 2020-06-17End: 2021-10-31Updated: 2021-12-14
Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders
CompletedNCT05103228
Peter Kovacs MDInfertility, Ovarian Dysfunction
Start: 2021-12-02End: 2023-07-20Updated: 2024-12-13
Real-world Evidence on Follitropin Delta Individual Dosing
RecruitingNCT05173597
University of LuebeckInfertility, Sterility
Start: 2021-12-08End: 2026-03-31Target: 850Updated: 2025-03-30
Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin
CompletedNCT05873725
Clinique OvoInfertility, IVF
Start: 2023-05-20End: 2024-03-19Updated: 2025-12-09

Related Papers

Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France.
2026-03-11
Ovarian stimulation with follitropin delta is safe and effective: results from the RITA randomized, double-blind, placebo-controlled trials.
2025-07-241 citations
P-643 When low serum AMH and high body weight converge: Is the algorithm-mandated first IVF-cycle maximum follitropin delta dose of 12 µg/d optimizing oocyte yield?
Human Reproduction2025-06-01
O-014 Cumulative live birth associated with number of oocytes in ovarian stimulation with follitropin delta: an individual patient data meta-analysis
Human Reproduction2024-07-01
P-680 Comparison of ovarian hyperstimulation syndrome (OHSS) rates resulting from conventional dosing versus personalized dosing of follitropin delta in ovarian stimulation, analysis of RITA, ESTHER-1 trials
Human Reproduction2024-07-01
O-013 Population pharmacokinetics of follitropin delta during ovarian stimulation
Human Reproduction2024-07-01
P-655 Live birth rate in the fresh cycle associated with number of oocytes in ovarian stimulation with individualised follitropin delta: an individual patient data meta-analysis
Human Reproduction2024-07-01
Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women
Clinical Drug Investigation2022-12-078 citations
Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection
Reproductive Biology and Endocrinology2022-10-0414 citations
P-788 A proof-of-concept study evaluating the effect of personalized dosages of follitropin delta in intra-uterine insemination (IUI): Personalized IUI Treatment Study (PITS)
Human Reproduction2022-06-29
P-143 The initial blastocyst size after warming is a strong predictor for clinical pregnancy in single vitrified blastocyst transfer
Human Reproduction2022-06-29
O-011 A prospective multicentre, non-interventional, real-world study to assess the pattern of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
Human Reproduction2022-06-29
Comparison of ovarian response to follitropin delta in Japanese and White IVF/ICSI patients.
2021-09-234 citations
O-114 Improved safety and efficiency of individualised versus conventional gonadotropin dosing for ovarian stimulation in IVF/ICSI: an individual patient meta-analysis (IPD-MA)
Human Reproduction2021-07-013 citations
P–650 Body weight is the main determinant of systemic follicle stimulating hormone (FSH) concentrations during controlled ovarian stimulation with follitropin delta
Human Reproduction2021-07-013 citations
O-110 A randomised, controlled, assessor-blind trial assessing clinical outcomes of individualised dosing with follitropin delta in Asian IVF/ICSI patients
Human Reproduction2021-07-01
A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients
Human Reproduction2021-06-0365 citations